NASDAQ: BIAF
Bioaffinity Technologies Inc Stock Ownership - Who owns Bioaffinity Technologies?

Insider buying vs selling

Have Bioaffinity Technologies Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BIAF insiders and whales buy or sell their stock.

BIAF Shareholders

What type of owners hold Bioaffinity Technologies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gary D. Rubin6.35%1,730,741$366.92kInsider
Steven Girgenti4.00%1,089,017$230.87kInsider
Roby Joyce2.38%649,745$137.75kInsider
Maria Zannes1.03%280,359$59.44kInsider
Vanguard Group Inc0.65%176,897$37.50kInstitution
Nathan M. Perlmutter0.61%166,089$35.21kInsider
Robert A. Anderson0.60%163,936$34.75kInsider
James Michael Edwards0.44%120,128$25.47kInsider
Geode Capital Management LLC0.44%118,689$25.16kInstitution
Peter S. Knight0.43%117,455$24.90kInsider

1 of 3

BIAF vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIAF1.88%17.65%
MYNZ10.08%0.00%
CHEK1.59%0.00%
TRIB0.54%0.00%
XWEL1.23%98.77%Net Buying

Bioaffinity Technologies Stock Ownership FAQ

Who owns Bioaffinity Technologies?

Bioaffinity Technologies (NASDAQ: BIAF) is owned by 1.88% institutional shareholders, 17.65% Bioaffinity Technologies insiders, and 80.48% retail investors. Gary D. Rubin is the largest individual Bioaffinity Technologies shareholder, owning 1.73M shares representing 6.35% of the company. Gary D. Rubin's Bioaffinity Technologies shares are currently valued at $366.92k.

If you're new to stock investing, here's how to buy Bioaffinity Technologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.